In my latest Forbes.com article (co-authored with my book co-author Charles Hooper), I (we) take on Naderite Sidney Wolfe's views on safe drugs and on conflicts of interest. We point out that despite Wolfe's view that consultants to drug companies should not be involved as advisers to the FDA, a study that found no biased effect of such consultants was done by none other than . . . Sidney Wolfe.
Unfortunately, the FDA has appointed Wolfe to an important position with its Drug Safety and Risk Management Committee.